| Erika Hagstrom, MD | |
|
2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804-7423 | |
| (406) 721-5600 | |
| Not Available |
| Full Name | Erika Hagstrom |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 2835 Fort Missoula Rd Bldg 3, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841685658 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 287108 (Massachusetts) | Secondary |
| 207N00000X | Dermatology | 113618 (Montana) | Primary |
| Entity Name | Western Montana Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942253182 PECOS PAC ID: 2466365002 Enrollment ID: O20031110000361 |
News Archive
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.
Should drug users and their families be trained in basic resuscitation methods, and be allowed to administer interim emergency naloxone to prevent overdose deaths whilst awaiting emergency medical help? If so why are the drug regulators so resistant to implementing these obvious harm reduction measures?
Wisconsin's rural hospitals hope to offset a state Medicaid cut with a tax that would bring more federal money to the hospitals. The proposed tax on the state's 59 'critical access' hospitals, all in rural areas, would prevent the hospitals from closing important services, officials say.
California Assemblyman Bill Monning, chair of the Assembly Committee on Health introduced AB 1453, which laid out a plan for what essential benefits will be covered in California under the Affordable Care Act. The proposed set of benefits is modeled on the Kaiser small group HMO plan
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), today announced that the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,569,551 entitled "Chemo-and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides," on the method of using OncoGenex' lead cancer drug candidate, OGX-011, to treat certain cancers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erika Hagstrom, MD Po Box 7609, Missoula, MT 59807-7609 Ph: (406) 721-5600 | Erika Hagstrom, MD 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804-7423 Ph: (406) 721-5600 |
News Archive
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.
Should drug users and their families be trained in basic resuscitation methods, and be allowed to administer interim emergency naloxone to prevent overdose deaths whilst awaiting emergency medical help? If so why are the drug regulators so resistant to implementing these obvious harm reduction measures?
Wisconsin's rural hospitals hope to offset a state Medicaid cut with a tax that would bring more federal money to the hospitals. The proposed tax on the state's 59 'critical access' hospitals, all in rural areas, would prevent the hospitals from closing important services, officials say.
California Assemblyman Bill Monning, chair of the Assembly Committee on Health introduced AB 1453, which laid out a plan for what essential benefits will be covered in California under the Affordable Care Act. The proposed set of benefits is modeled on the Kaiser small group HMO plan
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), today announced that the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,569,551 entitled "Chemo-and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides," on the method of using OncoGenex' lead cancer drug candidate, OGX-011, to treat certain cancers.
› Verified 9 days ago
Dr. Kevin Mcmullen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1821 South Ave W Ste 402, Missoula, MT 59801 Phone: 406-543-8512 Fax: 406-541-8513 | |
Jacob James Inda, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 | |
Charlotte L Kutsch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd, Ste 302, Missoula, MT 59804 Phone: 406-721-3497 | |
Shannon Kaye Foster, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 | |
Andrew R. Tegeder, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 Fax: 406-329-7192 | |
Jessica Kelly Sempler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 Fax: 406-329-7192 | |
Mr. Lance Randall Hinther, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2825 Fort Missoula Road, Suite 201, Missoula, MT 59804 Phone: 406-549-7556 Fax: 406-728-1868 |